Danaher (NYSE:DHR) Share Price Breaks Below Fifty Day Moving Average – Here’s Why

Shares of Danaher Corporation (NYSE:DHR – Get Free Report) passed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $224.82 and traded as low as $219.92. Danaher shares last traded at $220.4190, with a volume of 3,990,094 shares trading hands.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on DHR. Robert W. Baird upped their target price on shares of Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. UBS Group reissued a “buy” rating and set a $260.00 price target on shares of Danaher in a report on Thursday, October 22nd. Barclays boosted their price objective on Danaher from $255.00 to $260.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Monday, October 26th. Finally, Morgan Stanley increased their target price on Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research report on Monday, October 12th. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $242.91.

Get Our Latest Research Report on DHR

Danaher Price Performance

The firm’s fifty day simple moving average is $224.82 and its 200 day simple moving average is $201.66. The firm has a market cap of $155.07 billion, a P/E ratio of 36.08, a P/E/G ratio of 2.89 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63.

Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm had revenue of $6.55 billion for the quarter, compared to analysts’ expectations of $6.56 billion. During the same period in the previous year, the firm posted $1.89 earnings per share. The business’s revenue was up 8.3% compared to the same quarter last year. As a group, analysts forecast that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio is currently 26.19%.

Insider Activity

In related news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the transaction, the chief accounting officer owned 9,107 shares of the company’s stock, valued at $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gregory Milosevich sold 2,100 shares of the firm’s stock in a transaction on Monday, November 9th. The shares were sold at an average price of $230.62, for a total value of $484,302.00. Following the transaction, the executive vice president owned 22,367 shares in the company, valued at approximately $5,158,277.54. This represents a 8.58% decrease in their position. The disclosure for this sale is available in the SEC filing. 10.80% of the stock is owned by insiders.

Hedge Funds Weigh In On Danaher

Hedge funds have recently modified their holdings of the stock. Marquette Asset Management LLC boosted its position in shares of Danaher by 192.1% during the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after buying an additional 73 shares during the period. N.E.W. Advisory Services LLC purchased a new stake in shares of Danaher in the 2nd quarter valued at $25,000. Field & Main Bank acquired a new position in Danaher during the 2nd quarter worth about $29,000. Joseph Group Capital Management lifted its stake in Danaher by 62.4% during the 3rd quarter. Joseph Group Capital Management now owns 151 shares of the conglomerate’s stock worth $33,000 after acquiring an additional 58 shares in the last quarter. Finally, Solstein Capital LLC purchased a new position in Danaher during the 2nd quarter valued at about $33,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

About Danaher

(Get Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

Featured Articles

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.